Status:

COMPLETED

Ideas Moving Parents and Adolescents to Change Together (IMPACT)

Lead Sponsor:

Case Western Reserve University

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Overweight

Obese

Eligibility:

All Genders

11-15 years

Phase:

NA

Brief Summary

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institute of Health (NIH) has sponsored a consortium of four sites across the United States, entitled Childhood Obesity Prevention...

Detailed Description

The IMPACT trial will involve a 3-arm randomized controlled trial of three behavioral and educational interventions: (1) HealthyCHANGE, a behavioral approach focusing on building skills and increasing...

Eligibility Criteria

Inclusion

  • Students entering the 6th grade who are found at the standard school screenings to be overweight or obese
  • (BMI 85th- 94th percentile or \> 95th percentile for age/sex respectively)

Exclusion

  • Taking medications that alter appetite or weight (e.g. glucocorticoids, metformin, insulin, Risperidone (Risperdal), Olanzapine (Zyprexa), Clozapine(Clozaril), Quetiapine (Seroquel), Ziprasidone (Geodon), Carbamazepine (Tegretol), Valproic acid (Depakote/Depakene/Depacon), Aripiprazole (Abilify), Orlistat (Xenical), Sibutramine (Meridia), Phentermine, Diethylproprion (Tenuate), Topirimate (Topamax), glitazones (thiazolidinediones)
  • Inability to understand English
  • Stage 2 hypertension or stage 1 hypertension with end organ damage (left ventricular hypertrophy, microalbuminuria)
  • Severe behavioral problems that preclude group participation (as reported by parent/guardian)
  • Child involvement in another weight management program
  • Family expectation to move from the region within 1 year
  • The presence of a known medical condition that itself causes obesity (e.g., Prader-Willi syndrome) or interfere with HbA1C ( sickle cell disease)

Key Trial Info

Start Date :

February 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 31 2017

Estimated Enrollment :

360 Patients enrolled

Trial Details

Trial ID

NCT01514279

Start Date

February 1 2011

End Date

January 31 2017

Last Update

August 25 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Case Western Reserve University

Cleveland, Ohio, United States, 44106